Benzinga - Wed, 24 Feb 2021 04:35:09 -0400
Benzinga - Tue, 23 Feb 2021 11:25:58 -0400
Benzinga - Fri, 22 Jan 2021 05:54:13 -0400
Benzinga - Thu, 21 Jan 2021 13:36:43 -0400
Benzinga - Thu, 21 Jan 2021 13:01:09 -0400
Benzinga - Thu, 21 Jan 2021 08:01:54 -0400
load more
Sector: Health Care.Industry: Biotechnology
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS-0.500-0.310 0.1900
REV15.410M16.373M963.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CTMXCytomX Therapeutics2.37%504M

CytomX Therapeutics Company Questions & Answers

Q

How do I buy CytomX Therapeutics (CTMX) stock?

A

You can purchase shares of CytomX Therapeutics (NASDAQ: CTMX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CytomX Therapeutics's (CTMX) main competitors?

A

Other companies in CytomX Therapeutics’s space includes: Gamida Cell (NASDAQ:GMDA), Jounce Therapeutics (NASDAQ:JNCE) and Inozyme Pharma (NASDAQ:INZY).

Q

What is the target price for CytomX Therapeutics?

A

The latest price target for CytomX Therapeutics (NASDAQ: CTMX) was reported by Guggenheim on 2020-09-22. The analyst firm set a price target for 0.00 expecting CTMX to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

How much is CytomX Therapeutics (CTMX) stock ?

A

The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $7.78 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next CytomX Therapeutics (CTMX) dividend?

A

There are no upcoming dividends for CytomX Therapeutics.

Q

When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?

A
CytomX Therapeutics’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for CTMX?

A

There is no upcoming split for CytomX Therapeutics.